scispace - formally typeset
M

Michael Gurevich

Researcher at Sheba Medical Center

Publications -  73
Citations -  1829

Michael Gurevich is an academic researcher from Sheba Medical Center. The author has contributed to research in topics: Multiple sclerosis & Medicine. The author has an hindex of 19, co-authored 61 publications receiving 1219 citations.

Papers
More filters
Journal ArticleDOI

Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

TL;DR: The National Multiple Sclerosis Society and other expert organizations recommended that all patients with MS should be vaccinated against COVID-19 as discussed by the authors, however, they did not recommend that all MS patients with mild relapses be vaccinated.
Journal ArticleDOI

COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021.

TL;DR: In this article, risks related to vaccinating patients with multiple sclerosis (MS) need to be carefully assessed, since vaccination against coronavirus disease 2019 (COVID-19) became available.
Journal ArticleDOI

Blood transcriptional signatures of multiple sclerosis: unique gene expression of disease activity.

TL;DR: It is indicated that gene expression patterns in PBMCs contain information about a remote‐target disease process that may be useful for diagnosis and future tailoring of therapeutic strategies for MS.
Journal ArticleDOI

Autoimmunity gene expression portrait: specific signature that intersects or differentiates between multiple sclerosis and systemic lupus erythematosus

TL;DR: Investigation of the gene expression signature of peripheral blood mononuclear cells in MS and SLE in comparison to healthy subjects suggests increased MMP activity in target tissues as a result of the lack of feedback mechanism.